Literature DB >> 19636279

Pharmacokinetics of prophylactic micafungin in very-low-birth-weight infants.

Mayumi Kawada1, Noriyasu Fukuoka, Masatoshi Kondo, Kaoru Okazaki, Takashi Kusaka, Kou Kawada, Susumu Itoh.   

Abstract

We evaluated the use of micafungin as a prophylaxis in very-low-birth-weight infants. Micafungin was first administered to 25 very-low-birth-weight infants 12 to 24 hours after birth at a dose of 1 mg/kg/d. the apparent volume of distribution, the apparent elimination rate constant, the elimination half-life, and the total body clearance (mean +/- SD) were 0.76 +/- 0.28 L/kg, 0.12 +/- 0.041 1/h, 6.7 +/- 2.2 h, and 0.089 +/- 0.047 L/kg/h, respectively.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19636279     DOI: 10.1097/INF.0b013e3181a0cfd1

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  4 in total

Review 1.  Safety of micafungin in infants: insights into optimal dosing.

Authors:  Simon Ascher; Phillip Brian Smith; Daniel K Benjamin
Journal:  Expert Opin Drug Saf       Date:  2011-01-13       Impact factor: 4.250

2.  Very-low-birth-weight infants, prophylactic micafungin or fluconazole.

Authors:  Luis Gonzalez-Granado
Journal:  Indian J Pharmacol       Date:  2010-12       Impact factor: 1.200

Review 3.  Clinical Pharmacokinetics and Pharmacodynamics of Micafungin.

Authors:  Roeland E Wasmann; Eline W Muilwijk; David M Burger; Paul E Verweij; Catherijne A Knibbe; Roger J Brüggemann
Journal:  Clin Pharmacokinet       Date:  2018-03       Impact factor: 6.447

Review 4.  Micafungin in premature and non-premature infants: a systematic review of 9 clinical trials.

Authors:  Paolo Manzoni; Chunzhang Wu; Lorraine Tweddle; Emmanuel Roilides
Journal:  Pediatr Infect Dis J       Date:  2014-11       Impact factor: 2.129

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.